NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today reported that its third-quarter revenues declined 2 percent due to the negative impact of acquisitions and foreign currency translation.

The firm's net income, though, inched up around 1 percent as it posted lower costs for the quarter. The results beat analysts' estimates on both the top and bottom line.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.